ACET Adicet Bio Inc

Price (delayed)

$2.94

Market cap

$27.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.58

Enterprise value

$9.94M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” ...

Highlights
ACET's EPS has surged by 62% year-on-year and by 28% since the previous quarter
Adicet Bio's debt has decreased by 22% YoY and by 6% QoQ
The quick ratio has decreased by 10% from the previous quarter but it has increased by 9% YoY
Adicet Bio's equity has decreased by 15% QoQ and by 6% YoY

Key stats

What are the main financial stats of ACET

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
-1.67%
1 week
0.68%
1 month
-46.84%
1 year
-73.22%
YTD
-65.08%
QTD
-58.82%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$95.55M
Net income
-$91M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 21% YoY and by 8% QoQ
ACET's operating income is up by 21% YoY and by 8% from the previous quarter

Price vs fundamentals

How does ACET's price correlate with its fundamentals

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.27
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS has surged by 62% year-on-year and by 28% since the previous quarter
ACET's price to book (P/B) is 70% lower than its 5-year quarterly average of 0.9 and 55% lower than its last 4 quarters average of 0.6
Adicet Bio's equity has decreased by 15% QoQ and by 6% YoY

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE is up by 11% YoY and by 7% QoQ
Adicet Bio's return on assets has increased by 11% YoY and by 6% QoQ
Adicet Bio's ROIC has increased by 8% YoY and by 6% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
Adicet Bio's total liabilities has decreased by 16% YoY and by 6% from the previous quarter
The company's total assets fell by 13% QoQ and by 8% YoY
Adicet Bio's debt is 88% lower than its equity
Adicet Bio's debt has decreased by 22% YoY and by 6% QoQ
Adicet Bio's equity has decreased by 15% QoQ and by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.